Patients with multidrug-resistant HIV and HIV RNA levels of more than 5000 copies per milliliter were randomly assigned to a four-month structured interruption of treatment followed by a change in antiretroviral regimen ( treatment-interruption group ) or to an immediate change in regimen ( control group ) .
